AB

ATS Beteiligungsverwaltung

Description

ATS Beteiligungsverwaltung GmbH (Munich)

Investor Profile

ATS Beteiligungsverwaltung has made 3 investments, with 0 in the past 12 months and 33% as lead.

Stage Focus

  • Series E (33%)
  • Series D (33%)
  • Series C (33%)

Country Focus

  • Germany (100%)

Industry Focus

  • Biopharma
  • Biotechnology
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does ATS Beteiligungsverwaltung frequently co-invest with?

IF
Europe, Basel-Landschaft, Switzerland, Bubendorf
Co-Investments: 1
VI Partners
Europe, Schwyz, Switzerland, Altendorf
Co-Investments: 1
Landesbank Baden Wurttemberg
Europe, Baden-Wurttemberg, Germany, Stuttgart
Co-Investments: 1
Future Capital
Europe, Hessen, Germany, Frankfurt
Co-Investments: 3
F
Africa, Kadiogo, Burkina Faso, Ouagadougou
Co-Investments: 1
MIG Capital
Europe, Bayern, Germany, München
Co-Investments: 2

What are some of recent deals done by ATS Beteiligungsverwaltung?

Ganymed Pharmaceuticals

Mainz, Rheinland-Pfalz, Germany

Ganymed Pharmaceuticals is a biopharmaceutical developing therapeutic drugs designed to kill tumor cells without harming healthy tissues.

BiopharmaBiotechnologyPharmaceutical
Series ENov 18, 2013
Amount Raised: $60,769,258
Ganymed Pharmaceuticals

Mainz, Rheinland-Pfalz, Germany

Ganymed Pharmaceuticals is a biopharmaceutical developing therapeutic drugs designed to kill tumor cells without harming healthy tissues.

BiopharmaBiotechnologyPharmaceutical
Series DNov 19, 2008
Amount Raised: $81,776,127
Ganymed Pharmaceuticals

Mainz, Rheinland-Pfalz, Germany

Ganymed Pharmaceuticals is a biopharmaceutical developing therapeutic drugs designed to kill tumor cells without harming healthy tissues.

BiopharmaBiotechnologyPharmaceutical
Series CSep 24, 2007
Amount Raised: $47,482,979